Milner Executive Director Cathy Tralau-Stewart attends J.P. Morgan’s 43rd Annual Healthcare Conference
We are delighted that our Executive Director – Dr Cathy Tralau-Stewart – was invited to attend J.P. Morgan’s 43rd Annual Healthcare Conference this week. Cathy was pleased to connect with global industry leaders, emerging fast-growth companies, innovative...
Milner Institute welcomes affiliate network to first B2B Matchmaking Event
Last week, 40 Milner Affiliates joined our inaugural B2B Matchmaking Event here in Cambridge, bringing together a diverse range of start-ups, biotechs and larger services and CRO partners, as well as some of the pharma partners in the Milner Therapeutics Consortium....
Milner joins Cambridge-ARIA collaboration to create new technologies for transforming brain health
We are delighted that the Milner Therapeutics Institute (MTI) has joined a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners, to engineer a new generation of neuro-technologies designed to treat depression, dementia, chronic...
Milner Institute awarded £7m to enable Functional Genomics Screening Laboratory as part of UK wide initiative
We’re delighted to announce that the Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), awarded £7m to help establish the MRC-AstraZeneca-University of Cambridge joint Functional Genomics...
Drug Discovery World interviews Milner Institute Head of Research
Earlier this year, our Head of Research Dr Nicola McCarthy sat down with Megan Thomas, Multimedia Editor at Drug Discovery World, to explore Nicola’s role at the MTI, her career journey, and her views on the current opportunities and challenges in the field of drug...
Cambridge Biomedical Campus welcomes Milner Affiliate Cytiva
Global life sciences leader and Milner affiliate Cytiva recently established a footprint in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus (CBC), further developing relationships with the Milner Institute and the Cambridge Stem Cell Institute...
Milner Institute celebrates success of 2024 Pitch Day and Therapeutics Symposium
Last week, we were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together. On 1st July, we hosted our Milner Pitch Day at St Catharine’s College, which aimed to accelerate innovative ideas toward...
Milner welcomes Flagship Pioneering to learn more about the Institute’s unique model
We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited the Institute to learn more about the Milner model and discuss how we might work together in future. It was fantastic to...